Steinhart Richard I

Steinhart Richard I is listed in filings as Chief Financial Officer at BioXcel Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 22, 2026, including sale activity. Recent filings connect the profile to BioXcel Therapeutics, Inc. (BTAI), Atossa Therapeutics, Inc. (ATOS), and Actinium Pharmaceuticals, Inc. (ATNM). The current snapshot covers public activity from Jun 18, 2024 to May 22, 2026. Reported amounts are shown as $7.4K to $357.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.